Mesoblast Ltd - ADR

XNAS:MESO

17.32

-0.54 (-3.02%)

5:29:17 PM EDT: $17.31 -0.01 (-0.06%)

Market Cap (Intraday)	2.24B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	288.67

See more stats

Estimates Current Quarter

Revenue	$54.9 Million
Adjusted EPS	-$0.04

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Mesoblast Ltd - ADR Stock, XNAS:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000

Australia

Phone: +61.3.9639.6036

Number of Employees: 73

http://www.mesoblast.com

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.